Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2016
published in
- Diabetes, obesity & metabolism Journal
has subject area
- Age Factors
- Aged
- Blood Glucose
- Clinical Trials, Phase III as Topic
- Diabetes Mellitus, Type 2
- Diarrhea
- Female
- Glucagon-Like Peptides
- Glycated Hemoglobin
- Humans
- Hypoglycemia
- Hypoglycemic Agents
- Immunoglobulin Fc Fragments
- Least-Squares Analysis
- Male
- Middle Aged
- Nausea
- Recombinant Fusion Proteins
- Treatment Outcome